Confirmatory real-time qPCR showed a dramatic up-regulation of LCN2 in AH patients, which was not observed in other liver diseases including nonalcoholic steatohepatitis (NASH), HCV-induced chronic hepatitis and HCV-induced compensated cirrhosis. This evidence concerns the gene LCN2 and metabolic dysfunction-associated steatohepatitis.